Japan PHarmacological Audit study of Safety and Efficacy in Real world

Japan PHarmacological Audit study of Safety and Efficacy in Real world - Phase-R

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013326

Enrollment

850

Registered

2014-03-04

Start date

2014-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with pathologically or clinically diagnosed cancer 2) In- and out-patients receiving palliative care by palliative care team or at palliative care unit

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
patient-reported symptom severity	—

Secondary

Measure	Time frame
1) proxy-rated symptom severity 2) adverse event	—

Countries

Japan

Contacts

Public ContactChieko Suzuki

Seirei Mikatahara Hospital Palliative and Supportive care Division

jmmorita@sis.seirei.or.jp053-436-1251

Outcome results